Baker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah MD*, Nizar Saaydah MD* ABSTRACT

Size: px
Start display at page:

Download "Baker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah MD*, Nizar Saaydah MD* ABSTRACT"

Transcription

1 Renal Cell Carcinoma Clinical Presentation and Histopathological Findings: A Retrospective Analysis of a Jordanian Population at King Hussein Medical Center Baker Alabbadi MD*, Ali Alasmar MD*, Ayman Alqarallah MD*, Nizar Saaydah MD* ABSTRACT Objective: To assess renal cell carcinoma cases and analyze the tumor characteristics in terms of clinical presentation, patient s demographics and the histopathological findings. Methods: This retrospective study included 99 patients with renal masses, of both sexes and different age groups, who presented at our urology department at Prince Hussein Center for Urology and Organ Transplant with various clinical presentations. Patients were scheduled for nephrectomies during the period of January st 0 to April st 0. Demographic data were retrieved and reviewed with the histopathological reports obtained from the histopathology department at Prince man laboratory research center. Results: Our patients ranged in age from to 80 years old with male : female incidence ratio of.5:(p). Renal mass was incidentally discovered in 4.4% of cases (p). Radical nephrectomy was performed in 90.9% of cases. Clear cell renal cell carcinoma was diagnosed in.% of patients (p). Conclusion: Clear renal cell carcinoma subtype grade is the most frequent type of renal cell carcinoma in our Jordanian population. Renal cell carcinoma occurs commonly in males, with no metastases in females and with 6.% metastases in males. Key words: Carcinoma, Demographics, Grading, Histopathology, Renal. JRMS March 05; (): 8- / DO: 0.86/00098 ntroduction Renal cell carcinoma occupies 85% of kidney cancers. () The factors most commonly accompanying the increased renal cell carcinoma risk in epidemiological investigations in white people are obesity, hypertension and cigarette smoking, which account for less than half of these cancers. () Renal cell carcinoma comprises 4% of all new primary cancers, and 85% of kidney cancers are renal parenchyma (renal cell) carcinomas. () Renal cell carcinoma (RCC) is twice as frequent in males than females, with the mean age of early sixties. Renal cell carcinoma accounts for -% of all solid neoplasms discovered by ultrasound each year. () Renal cell carcinoma is the 0 th leading cause of cancer deaths globally. () Enhanced radiological technology caused early diagnosis and reduction in the size of tumor, but at the same time there has been an increase in the frequency of big and late stage renal cell carcinoma. Kidney carcinoma frequency is rising *From the Department of Urology, Prince Hussein Bin Abdullah the nd Center, King Hussein Medical Center, (KHMC), Amman-Jordan Correspondence should be addressed to Dr. B. Alabbadi, (KHMC), layanalis@yahoo.com Manuscript received May 5, 04. Accepted August 4, 04 8 Vol. No. March 05

2 .% yearly for men and.% yearly for women. () The diagnostic procedures for co-morbidities can clarify incidental findings of localized renal cell tumors. Most of the cases of renal cell carcinoma are discovered incidentally while performing ultrasound or CT scan for other causes. () The classic triad of presentation includes flank pain, gross hematuria and a palpable abdominal mass and accounts for 6-0% of presentation. () The rising incidence of advanced chronic kidney disease can lead to high kidney medical alert with increased diagnosis of early renal tumors, but unfortunately, the most frequent co-morbidities (HTN and DM) are not generally screened with radiological procedures. This frequency trend suggests that the biology of renal carcinoma can differ. () The objective of this analysis was to assess the demographic and pathological characteristics of RCC diagnosed and treated by members of the Prince Hussein Center for Urology and Organ Transplant and Princess man for laboratory research center during the study period. Methods Our retrospective study included 99 patients who had nephrectomies for renal masses during the period of January st 0 to April st 0. The sample comprised both genders and various age groups, who had presented at our urology department at Prince Hussein Center for Urology and Organ Transplant with different clinical presentations. Approval from our local ethics committee was secured. Certain data were retrieved and reviewed with the histopathological reports obtained from the histopathology department at Prince man center. The demographic characteristics included age, gender, clinical presentation (loin pain, hematuria, incidental), type of nephrectomy, risk factors (smoking, hypertension and obesity) and ABO group data. Renal cell carcinoma characteristics including anatomical and pathological issues were investigated including laterality, tumor location, kidney weight, tumor size, subtype and metastases. The tumor grading was related to age and gender for significance. Data collected from all patients included age, gender, BM (weight and height), histological subtype, the presence of known risk factors for RCC (history of smoking, Hypertension and obesity) and clinical presentation (incidental or symptomatic: hematuria, palpable mass, flank pain, weight loss, fever and night sweats). Body mass index was calculated for all patients by dividing the weight of the patient (kg) by square height (m ). Tumor histology was classified according to the Heidelberg classification. () The subtypes of RCC reported in our investigation included: clear cell, papillary, chromophobe, collecting duct and unclassified carcinomas. Statistical Analysis Descriptive statistics of demographics and pathologic variables were conducted for comparison between groups of patients. The Chisquare test was used to compare the frequency of categorical variables between groups. Students t test or variance was used to compare continuous variables. p was considered significant. Results Of the 99 patients, 6.6% (6) were men and 6.4% (6) were women (p). The male: female incidence ratio was.5:. The age ranged between and 80 years with a mean age of 5.5 years in the whole study (Table ). n terms of clinical presentation, incidental asymptomatic picture was shown in 4.4 %( 4) of cases while symptomatic picture was demonstrated in 56.6% (56) of cases (p>0.05). This type of tumor affected the right kidney in 49.5% (49) of cases and affected the left kidney in 50.5% (50) of cases (p>0.05) (Table ). Smoking history, hypertension and obesity (BM >0 kg/m ) were found in 0.% (n=0),.% (n=) and 66.% (n=66) of patients, respectively. Men (n=) were found to have more the combined three risk factors than women (n=) (p). Computed tomography was the main diagnostic method. The majority of cases were localized tumors 94.9% (n=94) and metastases were reported in 5.% (n=5) of male patients only (one at renal sinus by papillary grade, two with brain vascular involvement by one clear cell RCC grade and one clear cell RCC grade V and two with adrenal involvement by clear cell RCC grade ). Vol. No. March 05 9

3 Table : Demographic characteristics of patients Females Males P Number 6 6 Age Range Mean Clinical presentation ncidental Loin pain Hematuria Loin pain + hematuria Nephrectomy Radical Partial Risk factors Smoking Obesity Hypertension Combined ABO group A B AB O (58.%) 0(.8%) 5(.9%) 0(0%) > >0.05 > (4.6%) 9(0.%) (.5%) (4.8%) Table. Renal cell carcinoma characteristics (anatomical and pathological) Females Males P Kidney side Right Left Kidney pole Upper Lower Middle Whole Kidney weight Least Heighest Tumor size Least Heighest Subtype Clear cell Chromophobe Papillary Undifferentiated with sarcomatoid Collecting duct g 500g ---- cm cm Metastasis 0 5 Grade V Of the total patients 90.9% (n=90) underwent radical nephrectomy while 9.% (n=9) underwent partial nephrectomy (Table ). The most frequent subtype of RCC was clear cell subtype affecting.% (n=) of patients ( females and 44 males), followed by the papillary with 4.% (n=4) of patients ( female and males) and the chromophobe subtype with 0.% (n=0) of patients ( females and 4 males). Sarcomatoid differentiation was recorded in.0% of patients (n=), one female (grade ) and males (grade 4). One male patient (.0%) had multilocular cystic RCC grade for which he underwent partial nephrectomy (Table V). 0 Vol. No. March 05

4 Table. Tumor grading with age P Female CC CP Male CP CC CC CC CP CCV CC CC CC CP CCV PAP PAPV SARCV Cystic CC: clear cell, CP: chromophobe, PAP: papillary, SARC: sarcomatoid Table V: Tumor grading with gender Clear cell (CC) V Chromophobe(CP) PAPLLARY(PAP) V SARCOMATOD(SARC) CC CC CP CP PAP CP CC 4 CC CC PAP PAPV CCV CC 4 CCV SARC CC 4 CP CCV PAP CC 5 PAP CC 4 CC 4 PAP CP CC CC Female Male P V Cystic 0 Table V: Overall incidence if RCC grading Female Male P Grade 5 Grade 0 Grade 0 Overall renal cell carcinoma grading was most commonly found in males grade (n=0, 0.%) with a total of 4 (4.5%) including males and females (Table V). Discussion Although some tumors have a clear and specific induced effect cause, renal cell carcinoma is not of these. There are clinical, professional and material factors incriminating in renal cell carcinoma tumorigenesis such as smoking, asbestos, organic solvents, viral infections, radiation therapy and others. (4) An increased frequency of RCC (. fold risk ratio) in smokers was shown directly related to number of cigarettes and inversely with age of beginning of smoking due to carcinogen dimetilnitrosamine. Smoking was reported in 0% of RCC cases. (4) n our investigation, smoking was shown to have a frequency of 0.% in our Jordanian population diagnosed as renal cell carcinoma. This was regarding tobacco importance in RCC genesis but it was shown that smoking increases.84 fold the Vol. No. March 05

5 risk of progression of the disease postoperatively. (4) Diet and obesity may increase the risk of renal cell carcinoma in addition to chronic renal failure, hypertension and dialysis. (5) Diuretics may cause a high frequency of RCC in patients with chronic intake. Hydrochlorothiazide and furosemide cause tubular cell adenomas and adenocarcinomas of the kidney. (6) Obesity may induce about 0% of renal cancers. The relative risk was increased. folds in males and. folds in females. () n our study, the frequency of obesity was 66.%, accounting 0.% in females and 6.4% in males. High level of endogenous estrogen in the obese patient is the incriminating agent. Obesity induces arterionephrosclerosis which can make renal tubules more susceptible to carcinogens. Hypertension can be considered as significant for the development of kidney cancer by inducing metabolic and functional changes in the renal tubular cells producing carcinogenesis. (8) Hypertension was seen in 4.% in females and in 49.5% in males in our study, accounting for.% of our total study group exposed to RCC. Hypertension is known to be a general risk factor for some types of cancers because hypertension and cancer share some frequent risk factors such as smoking, diabetes, obesity and others. A recent analysis demonstrated the excess cancer risk to be around 0-0%. Combining these risk factors, we found that.% of our patients, had combined these three factors, which we consider that these should alert the practitioner in his research. t is very difficult to find a direct cause regarding any cancer. To answer this question, a comprehensive epidemiological study is required during a long duration of time with careful follow up. Discrepancies in age, sex and geographic distribution were included in cancer origin. Most of renal cell carcinoma are sporadic and 4% are familiar (5) with a hereditary pattern. Worldwide among urological tumors, renal cell carcinoma occupies the third place in frequency after prostate carcinoma and transitional cell carcinoma of bladder. Renal cell carcinoma represents % of adult malignancies, occupying the 0 th place in males and 4 th place in females with a male to female ratio of :. (9) The male:female ratio in our study is.:. The peak frequency occurs in the 6 th decade with 80% of cases occurring within the years old inhabitants. () Renal cell represents 85-90% of renal parenchymal malignancies. () Since 90, frequency of RCC has been increasing from 0. to 4. /00000 in females and from.6 to 9.6 /00000 in males. (0) ncreasing frequency is explained by easier diagnosis (routine use of CT scan) and not by genuine increased frequency of RCC. Renal cell carcinoma is found incidentally in.5% of the autopsies. (0) Clear cell renal carcinoma is the most frequent subtype accounting for 0-80% of cases, then comes the papillary with 0-0 % of cases, chromophobe with 5% of cases and finally the collecting duct and the unclassified types with an incidence of <% of cases. Different grades and stages are encountered postoperatively with variable outcome and prognostic value. n Brazil, Aguinaldo et al., showed that male patients predominated and the mean age was near 60 years. Most of the patients presented with localized disease (% with RCC stage ). Abdominal CT scan was used in 9.% of patients for diagnostic purposes. () Most of the patients worldwide are presented with localized disease (% with stage ). () They found that the proportion of patients with metastatic disease was 9.5% (in our study it was 5.%) and that males present with more advanced disease at diagnosis than females, as in our study. n their study it was demonstrated that there was no association between stage and the presence of risk factors which were smoking, hypertension and obesity, the same factors as in ours. Although they did not find an association between the presence of clear cell histology and more advanced disease, we found that metastases were due to clear cell pathology, although the number was not significant. Limitations of the Study A limitation of the study was the small number and limited to one center. We believe that this study must be generalized to include more subjects at different regions of Jordan and in various centers to have a general view of such disease. Conclusion Regarding RCC, the etiology and risk factors are not fully understood. There is proof that some conditions, drugs, habits or genetics can play a Vol. No. March 05

6 role in development of RCC in Jordanian population, although international research show controversial results. Future campaigns need to be done to reduce smoking, obesity and hypertension in our Jordanian population to decrease hopefully the incidence of renal cell carcinoma. References. Rebecca S, Jiemin MA, Zhaohul Z, et al. Cancer statistics. Ca Cancer J Clin 04; 64: Loren L, Robert ET, Joseph MC. Renal cell cancer among African Americans:an epidemiologic review. BMC Cancer 0; :. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumors. J Pathol 99; 8: Hunt JD, van der Hel OL, McMillan GP, Boffetta P, et al. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 4 studies. nternational J of Cancer 005; 4(): Pascual D, Borque A. Epidemiology of kidney cancer. Adv Urol 008; Franz HM. Risk factors for renal cell carcinoma:hypertension or diuretics? Kidney international 005; 6:4-5.. Amling CL. The association between obesity and the progression of prostate and renal cell carcinoma. Urol Oncol 004; (6): Joanne SC, Kendra S, Barry G, et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 0; (6): McLaughlin JK, Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol 000; (): Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 006. Annals of Oncology 00; 8(): Aguinaldo CN, Stenio de CZ, Otavio ACC, et al. Epidemiologic characteristics of renal cell carcinoma in Brazil. nternational Brazil J Urol 00; 6(). Vol. No. March 05

Renal tumors of adults

Renal tumors of adults Renal tumors of adults Urinary Tract Tumors 2%-3% of all cancers in adults. The most common malignant tumor of the kidney is renal cell carcinoma. Tumors of the lower urinary tract are twice as common

More information

Case Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma of Thyroid

Case Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma of Thyroid Case Reports in Urology Volume 2013, Article ID 651081, 4 pages http://dx.doi.org/10.1155/2013/651081 Case Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma

More information

Renal Cell Carcinoma: a Clinico-Pathological Characteristics and Evaluation of Twenty Four Patients

Renal Cell Carcinoma: a Clinico-Pathological Characteristics and Evaluation of Twenty Four Patients Sci. Med. J., Jul. - Oct. 2007; 19(3-4): 19-25 ISSN 1110-5607 ESCME Original Article Renal Cell Carcinoma: a Clinico-Pathological Characteristics and Evaluation of Twenty Four Patients Mohamed El-Atrebi,

More information

Renal Parenchymal Neoplasms

Renal Parenchymal Neoplasms Renal Parenchymal Neoplasms د. BENIGN TUMORS : Benign renal tumors include adenoma, oncocytoma, angiomyolipoma, leiomyoma, lipoma, hemangioma, and juxtaglomerular tumors. Renal Adenomas : The adenoma is

More information

Characteristics of Renal Cell Carcinoma in Dr. Hasan Sadikin General Hospital Bandung,

Characteristics of Renal Cell Carcinoma in Dr. Hasan Sadikin General Hospital Bandung, 644 AMJ December 2016 Characteristics of Renal Cell Carcinoma in Dr. Hasan Sadikin General Hospital Bandung, 2010 2014 Dicky Suryana Putra, 1 Sri Suryanti, Aaron Tigor Sihombing 3 1 Faculty of Medicine

More information

Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population

Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population DOI 10.1007/s10147-015-0812-9 ORIGINAL ARTICLE Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population Yasunobu

More information

GUIDELINES ON RENAL CELL CARCINOMA

GUIDELINES ON RENAL CELL CARCINOMA GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists

More information

Guidelines on Renal Cell

Guidelines on Renal Cell Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health Technology Appraisal Cabozantinib for untreated locally advanced or metastatic renal cell carcinoma Final scope Remit/appraisal objective To appraise

More information

Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association

Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association 218 Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney: Previously Unreported Association Min Su Cheong a Dong Hun Koo a In-Sung Kim a Kyung Chul Moon b Ja Hyeon Ku a

More information

GUIDELINES ON RENAL CELL CANCER

GUIDELINES ON RENAL CELL CANCER 20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance

More information

St. Dominic s Annual Cancer Report Outcomes

St. Dominic s Annual Cancer Report Outcomes St. Dominic s 2017 Annual Cancer Report Outcomes Cancer Program Practice Profile Reports (CP3R) St. Dominic s Cancer Committee monitors and ensures that patients treated at St. Dominic Hospital receive

More information

Urological Tumours 1 Kidney tumours 2 Bladder tumours

Urological Tumours 1 Kidney tumours 2 Bladder tumours Urological Tumours 1 Kidney tumours 2 Bladder tumours Tim Bracey SpR Histopathology Derriford Hospital Kidney tumours What are we going to talk about?! Anatomy of urinary tract! Types of kidney tumours!

More information

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright

More information

RCC in ADPKD / CKD / ESRD

RCC in ADPKD / CKD / ESRD RCC in ADPKD / CKD / ESRD FOIU 2018 David A. Goldfarb, MD,FACS Professor of Surgery, Cleveland Clinic Lerner College of Medicine Glickman Urological and Kidney Institute Cleveland Clinic, Cleveland, Ohio

More information

MULTILOCULAR CYSTIC RENAL CELL CARCINOMA

MULTILOCULAR CYSTIC RENAL CELL CARCINOMA MULTILOCULAR CYSTIC RENAL CELL CARCINOMA Khalaf M. Al-Jader, MD* ABSTRACT Objective: Multilocular cystic renal cell carcinoma appears to be uncommon subtype of renal cell carcinoma with characteristic

More information

Solitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma

Solitary Contralateral Adrenal Metastases after Nephrectomy for Renal Cell Carcinoma Original Report ISSN 1537-744X; DOI 10.1100/tsw.2004.39 Solitary Contralateral Adrenal after Nephrectomy for Renal Cell Carcinoma Nikolaos Antoniou, M.D. and Demetrios Karanastasis, M.D. General Hospital

More information

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES

DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,

More information

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown

Recruiting Active; not recruiting Completed Suspended Terminated. The biological sex of the patient. Female Unknown Clinical Data Form Kidney Carcinoma Clinical Trial Sequencing Project Page 1 The Clinical Data Form (CDF) should be completed for every case. This form can be completed at the time the samples are submitted,

More information

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report Case Study TheScientificWorldJOURNAL (2008) 8, 145 148 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.29 Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report C. Blick, N. Ravindranath,

More information

Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney

Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney Case Study TheScientificWorldJOURNAL (2004) 4, 965 968 ISSN 1537-744X; DOI 10.1100/tsw.2004.196 Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney M. Al-Assiri 1, M.F.

More information

Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma Associated with End-stage Renal Disease

Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma Associated with End-stage Renal Disease Jpn J Clin Oncol 2014;44(11)1096 1100 doi:10.1093/jjco/hyu117 Advance Access Publication 19 August 2014 Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma

More information

Case Based Urology Learning Program

Case Based Urology Learning Program Case Based Urology Learning Program Resident s Corner: UROLOGY Case Number 18 CBULP 2011 041 Case Based Urology Learning Program Editor: Associate Editors: Manager: Case Contributors: Steven C. Campbell,

More information

Urogenital Malignancies Oct 15-17,2010 Constantine Algeria. President of Jordan Oncology Society Secretary General of AMAAC

Urogenital Malignancies Oct 15-17,2010 Constantine Algeria. President of Jordan Oncology Society Secretary General of AMAAC Urogenital Malignancies Oct 15-17,2010 Constantine Algeria Sami Khatib, MD Consultant Clinical Oncologist President of Jordan Oncology Society Secretary General of AMAAC Amman-Jordan Mohammad Al Tarawneh,MD

More information

RENAL CELL CARCINOMA METASTASIZING TO PAROTID GLAND ABSTRACT

RENAL CELL CARCINOMA METASTASIZING TO PAROTID GLAND ABSTRACT CASE REPORT RENAL CELL CARCINOMA METASTASIZING TO PAROTID GLAND Mutahir A. Tunio 1, Mushabbab Al Asiri 2, Asim Ali Elbagir Mohammad 3, Khalid Riaz 4 1,4 Department of Radiation Oncology, King Fahad Medical

More information

Tumors of kidney and urinary bladder

Tumors of kidney and urinary bladder Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common

More information

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI

More information

The Incidental Renal Mass in the Primary Care Setting

The Incidental Renal Mass in the Primary Care Setting The Incidental Renal Mass in the Primary Care Setting Adele M. Caruso, MSN, CRNP Adult Nurse Practitioner The Perelman School of Medicine at the University of Pennsylvania Abstract There are approximately

More information

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) Universally recognized post-nephrectomy cancer treatment. Sampling: National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology

More information

Renal Mass Biopsy Should be Used for Most SRM - PRO

Renal Mass Biopsy Should be Used for Most SRM - PRO Renal Mass Biopsy Should be Used for Most SRM - PRO Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center GU Cancer Lead, Cancer Care Ontario Associate Professor,

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Presentation Outline Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 General Information

More information

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04 X:\FCDS_PUB\wwwroot\downloads\Teleconfere nces\2013 FCDS Educational Webcast Series February 28, 2013 1 Steven Peace, BS, CTR Susan Smith

More information

Renal Cancer. By Jamie Calderwood

Renal Cancer. By Jamie Calderwood Renal Cancer By Jamie Calderwood ("Kidney Cancer")*1 ("What are the different types of kidney mass?")*2 What is it? Renal cancer is more commonly known as kidney cancer. Wilms tumor Another name for kidney

More information

SAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012

SAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012 Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012 The Renal Cell Carcinoma (RCC) Disease Therapeutics Market GlobalData s analysis suggests

More information

JMSCR Vol 06 Issue 02 Page February 2018

JMSCR Vol 06 Issue 02 Page February 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i2.08 Pattern of Renal Tumors: A Tertiary

More information

Imaging characterization of renal clear cell carcinoma

Imaging characterization of renal clear cell carcinoma Imaging characterization of renal clear cell carcinoma Poster No.: C-0327 Congress: ECR 2011 Type: Educational Exhibit Authors: S. Ballester 1, A. Gaser 2, M. Dotta 1, M. F. CAPPA 1, F. Hammar 1 ; 1 2

More information

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22 Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22 Chief complaint Unknown fever for one month Hand tremor and left huge renal tumor was noted Present illness Suffered from fever for one month, hand

More information

(2/3 PRCC!) (2/3 PRCC!)

(2/3 PRCC!) (2/3 PRCC!) Approach to the Incidental Solid Renal Mass Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,

More information

Collecting Duct Renal Cell Carcinomas

Collecting Duct Renal Cell Carcinomas Collecting Duct Renal Cell Carcinomas Gabriel G. Malouf, MD, PhD Department of Medical Oncology Pitié-Salpêtrière Hospital Paris, France Fourteenth International Kidney Cancer Symposium Miami, Florida,

More information

Metastatic Potential in Renal Cell Carcinomas =7 cm: Swedish Kidney Cancer Quality Register Data

Metastatic Potential in Renal Cell Carcinomas =7 cm: Swedish Kidney Cancer Quality Register Data EUROPEAN UROLOGY 60 (2011) 975 982 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Eric C. Umbreit and R. Houston Thompson on pp.

More information

RENAL CELL CARCINOMA. About Renal cell carcinoma

RENAL CELL CARCINOMA. About Renal cell carcinoma RENAL CELL CARCINOMA Rcc, Grawitz Tumor A kidney cancer that originates in a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. Diagnosis Male & Female

More information

the urinary system pathology Dr. Fairoz A Eltorgman

the urinary system pathology Dr. Fairoz A Eltorgman the urinary system pathology Dr. Fairoz A Eltorgman Tumors of the renal pelvis & kidney Benign tumors of the renal pelvis: Hemangioma Leiomyoma Malignant tumors: Transitional cell carcinoma Squamous cell

More information

Five Views of Transitional Cell Carcinoma: One Man s Journey

Five Views of Transitional Cell Carcinoma: One Man s Journey September 2006 Five Views of Transitional Cell Carcinoma: One Man s Journey Amsalu Dabela, Harvard Medical School III Outline Overview: Renal Anatomy Our Patient s Story Diagnostic Imaging Studies Appearance

More information

6 UROLOGICAL CANCERS. 6.1 Key Points

6 UROLOGICAL CANCERS. 6.1 Key Points 6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when

More information

Complex case Presentations

Complex case Presentations Complex case Presentations Case Presentations April 2016 Lisa M Pickering Case presentations: chromophobe renal carcinoma 60 year old man. ECOG PS 0 No significant comorbodities August 2009: L radical

More information

Renal Mass Biopsy: Needed Now More than Ever

Renal Mass Biopsy: Needed Now More than Ever Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,

More information

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017 Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations

More information

Indications for Surgical Removal of Adrenal Glands

Indications for Surgical Removal of Adrenal Glands The adrenal glands are orange-colored endocrine glands which are located on the top of both kidneys. The adrenal glands are triangular shaped and measure about one-half inch in height and 3 inches in length.

More information

Renal Tumors in Transplantation

Renal Tumors in Transplantation Renal Tumors in Transplantation Kevin Morrison Clinical-Pathological Correlation September 15 th, 2004 Overview Case reports Neoplasia in transplantation Renal allograft tumors Native kidney RCC Role of

More information

Radical Nephrectomy for Renal Cell Carcinoma Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study

Radical Nephrectomy for Renal Cell Carcinoma Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study AJCP /ORIGINAL ARTICLE Radical Nephrectomy for Renal Cell Carcinoma Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study Kamran M. Mirza, MD, PhD, Jerome

More information

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective Role of imaging in RCC From Diagnosis to Treatment: the Radiologist Perspective Diagnosis Staging Follow up Imaging modalities Limitations and pitfalls Duangkamon Prapruttam, MD Department of Therapeutic

More information

Coexistence of Ovarian Cancer and Renal Cell Carcinoma

Coexistence of Ovarian Cancer and Renal Cell Carcinoma CASE REPORT Coexistence of Ovarian Cancer and Renal Cell Carcinoma Kuo-How Huang, 1 Shih-Dong Chung, 1 Shin-Yi Huang, 1,3 Shih-Chieh Chueh, 1 * Chi-An Chen, 2 Jun Chen 1 Coexistence of ovarian cancer and

More information

International Journal of Medical and Health Sciences

International Journal of Medical and Health Sciences International Journal of Medical and Health Sciences Journal Home Page: http://www.ijmhs.net ISSN:2277-4505 Case Report Squamous Cell Carcinoma Of Renal Pelvis- A Rare Case Report S. S. Inamdar* 1, Sainath

More information

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy. History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12

More information

Renal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others

Renal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of

More information

Prognostic Relevance of the Histological Subtype of Renal Cell Carcinoma

Prognostic Relevance of the Histological Subtype of Renal Cell Carcinoma Clinical Urology Prognostic Relevance of the Histological Subtype of RCC International Braz J Urol Vol. 34(1): 3-8, January - February, 2008 Prognostic Relevance of the Histological Subtype of Renal Cell

More information

UnusalPresentationofMetastasisfromaRenalCellCarcinoma-A CaseReportwithReviewofLiterature

UnusalPresentationofMetastasisfromaRenalCellCarcinoma-A CaseReportwithReviewofLiterature Global Journal of Medical Research: K Interdisciplinary Volume 18 Issue 8 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249-4618 &

More information

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,

More information

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud GENITOURINARY PATHOLOGY Kathleen M. O Toole Toole, M.D. RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a

More information

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation 246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras

More information

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018

Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of

More information

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Kidney Case 1 SURGICAL PATHOLOGY REPORT Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which

More information

Multifocal Renal Cell Carcinoma of Different Histological Subtypes in Autosomal Dominant Polycystic Kidney Disease

Multifocal Renal Cell Carcinoma of Different Histological Subtypes in Autosomal Dominant Polycystic Kidney Disease The Korean Journal of Pathology 2012; 46: 382-386 CASE REPORT Multifocal Renal Cell Carcinoma of Different Histological Subtypes in Autosomal Dominant Polycystic Kidney Disease Ki Yong Na Hyun-Soo Kim

More information

Hereditary Leiomyomatosis and Renal Cell Carcinoma Variant of Reed s Syndrome - A Rare Case Report

Hereditary Leiomyomatosis and Renal Cell Carcinoma Variant of Reed s Syndrome - A Rare Case Report American Research Journal of Urology Volume 1, Issue 1, pp:26-30 Case Hereditary Leiomyomatosis and Renal Cell Carcinoma Variant of Reed s Syndrome - A Rare Case Manas Babu, Devesh Bansal, Sony Mehta,

More information

SBRT for lung metastases: Case report

SBRT for lung metastases: Case report SBRT for lung metastases: Case report Guillermo de Velasco MD, PhD University Hospital 12 de Octubre @H12O_GUCancer @g_develasco Case report 71 years old man Smoker DM 2005 Right radical nephrectomy Histology:

More information

BREAST PAIN ASSESSMENT USING BREAST ULTRASOUND AT KING HUSSEIN MEDICAL CENTER IN JORDAN

BREAST PAIN ASSESSMENT USING BREAST ULTRASOUND AT KING HUSSEIN MEDICAL CENTER IN JORDAN BREAST PAIN ASSESSMENT USING BREAST ULTRASOUND AT KING HUSSEIN MEDICAL CENTER IN JORDAN Jamila Salem Al-Sarairah, MD, JBR*, Rawan Nahed Al-Hiari, MD, JBR *MD, JBR, Department of radiology, Breast imaging

More information

Is renal cryoablation becoming an effective alternative to partial nephrectomy?

Is renal cryoablation becoming an effective alternative to partial nephrectomy? Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University

More information

Sarcomatoid renal cell carcinoma: A case report and literature review

Sarcomatoid renal cell carcinoma: A case report and literature review Sarcomatoid renal cell carcinoma: A case report and literature review Michael Reiter 1*, Ryan Schwope 1, Arthur Clarkson 2 1. Department of Radiology, Brooke Army Medical Center, San Antonio USA 2. Department

More information

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

Kidney, Bladder and Prostate Neoplasia. David Bingham MD Kidney, Bladder and Prostate Neoplasia David Bingham MD typical malignant cytology of bladder washings 1 benign 2 malignant typical malignant cytology of bladder washings b Bladder tumor Non invasive papillary

More information

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1 Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013

More information

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma

Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma http://dx.doi.org/10.7180/kmj.2016.31.1.66 KMJ Case Report Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma Jeong Hyun Oh 1, Taek Sang Kim 1, Hyun Yul Rhew 1, Bong Kwon Chun

More information

Pathologic Characteristics of Solitary Small Renal Masses. Can They Be Predicted by Preoperative Clinical Parameters?

Pathologic Characteristics of Solitary Small Renal Masses. Can They Be Predicted by Preoperative Clinical Parameters? Anatomic Pathology / Pathology of Small Renal Masses Pathologic Characteristics of Solitary Small Renal Masses Can They Be Predicted by Preoperative Clinical Parameters? Tom DeRoche, MD, 1 Esteban Walker,

More information

Workup of a Solid Liver Lesion

Workup of a Solid Liver Lesion Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any

More information

Vincenzo Ficarra 1,2,3. Associate Editor BJU International

Vincenzo Ficarra 1,2,3. Associate Editor BJU International Partial Nephrectomy for RCC Vincenzo Ficarra 1,2,3 1 Director Department of Urology University of Udine, Italy 2 Associate Editor BJU International 3 Scientific Director OLV Robotic Surgery Institute,

More information

EVALUATION OF THE OUTCOME OF THE MANAGEMENT OF PATIENTS WITH RENAL CELL CARCINOMA

EVALUATION OF THE OUTCOME OF THE MANAGEMENT OF PATIENTS WITH RENAL CELL CARCINOMA International Invention Journal of Medicine and Medical Sciences (ISSN: 2408-7246) Vol. (9) pp. 99-204, November, 206 Available online http://internationalinventjournals.org/journals/iijmms Copyright 206

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar

More information

Sustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma

Sustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma JOURNAL OF CASE REPORTS 2015;5(1):280-284 Sustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma Chanchal Goswami, Aditi Mandal B. P. Poddar Hospital & Medical Research

More information

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer Clinical Urology Post-radiotherapy Prostate Biopsy for Recurrent Disease International Braz J Urol Vol. 36 (1): 44-48, January - February, 2010 doi: 10.1590/S1677-55382010000100007 Outcomes Following Negative

More information

Wilms Tumor and Neuroblastoma

Wilms Tumor and Neuroblastoma Wilms Tumor and Neuroblastoma Wilm s Tumor AKA: Nephroblastoma the most common intra-abdominal cancer in children. peak incidence is 2 to 3 years of age Biology somatic mutations restricted to tumor tissue

More information

Hey Doc, there s blood in my urine Evaluation of hematuria. Christian S. Kuhr, MD FACS May 4, 2018

Hey Doc, there s blood in my urine Evaluation of hematuria. Christian S. Kuhr, MD FACS May 4, 2018 Hey Doc, there s blood in my urine Evaluation of hematuria Christian S. Kuhr, MD FACS May 4, 2018 Objectives Understand the algorithm for hematuria evaluation Know the differential diagnosis for hematuria

More information

Unknown Slides Conference

Unknown Slides Conference Unknown Slides Conference Jae Y. Ro, MD, PhD Weill Medical College of Cornell Univ. The Methodist Hospital, and UT MD Anderson Cancer Center Houston, TX November 9, 2013 Amman, Jordan 25 th Congress of

More information

Pathology Mystery and Surprise

Pathology Mystery and Surprise Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor

More information

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target? New Frontiers in Urologic Oncology Juan Chipollini, MD Clinical Fellow Department of Genitourinary Oncology Moffitt Cancer

More information

Presentation of Cases /Audience Voting/Panel/Discussion

Presentation of Cases /Audience Voting/Panel/Discussion Presentation of Cases /Audience Voting/Panel/Discussion JJ Patard Tim O Brien Ninth European International Kidney Cancer Symposium Dublin 25-26 April 2014 Clinical case 1 63 years old women Medical past

More information

Advanced & Metastatic Renal Cell Carcinoma

Advanced & Metastatic Renal Cell Carcinoma Advanced & Metastatic Renal Cell Carcinoma An Update G. Renzulli January 2013 1 Overview of Cancers of the Kidney 2 Global Epidemiology 3 Global Epidemiology of Kidney Cancer 4 Globally, kidney cancer

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

Metastatic renal cancer (mrcc): Evidence-based treatment

Metastatic renal cancer (mrcc): Evidence-based treatment Metastatic renal cancer (mrcc): Evidence-based treatment José M. Ruiz Morales, M.D. Hospital Médica Sur April 18th, 2018 4th ESO-ESMO Latin American Masterclass in Clinical Oncology Disclosures Consulting:

More information

Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma

Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma Case Study TheScientificWorldJOURNAL (2009) 9, 5 9 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2009.6 Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting

More information

!! 2 to 3% of All New Visceral Cancers.!! Peak Incidence is 6th Decade!! M:F = 2:1

!! 2 to 3% of All New Visceral Cancers.!! Peak Incidence is 6th Decade!! M:F = 2:1 !! Kathleen M. O Toole, M.D.!! 2 to 3% of All New Visceral Cancers!! Peak Incidence is 6th Decade!! M:F = 2:1!! Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule 1 !!Conventional RCC! Clear

More information

Cancer. University of Illinois at Chicago College of Nursing

Cancer. University of Illinois at Chicago College of Nursing Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe

More information

250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW

250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW 250 CASES OF CARCINOMA OF URINARY BLADDER A PRELIMINARY REVIEW Pages with reference to book, From 102 To 105 S. Adeebul Hassan Rizvi, S. Anwar Naqvi ( Department of Urology, Dow Medical College and Civil

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Magn Reson Imaging Clin N Am 12 (2004) 587 591 Index Note: Page numbers of article titles are in boldface type. A Adenoma(s), adrenal, gadolinium-enhanced MR imaging in, 533 534 hyperfunctioning versus

More information

L. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD

L. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD Computed Tomography Urography (CTU) for Evaluation of Asymptomatic microscopic hematuria. Is intravenous contrast administration warranted for all patients? A retrospective evaluation utilizing ACR s Appropriateness

More information

See the latest estimates for new cases of kidney cancer and deaths in the US and what research is currently being done.

See the latest estimates for new cases of kidney cancer and deaths in the US and what research is currently being done. About Kidney Cancer Overview and Types If you have been diagnosed with kidney cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What Is

More information

Comparison of radiographic and pathologic sizes of renal tumors

Comparison of radiographic and pathologic sizes of renal tumors ORIGINAL Article Vol. 39 (2): 189-194, March - April, 2013 doi: 10.1590/S1677-5538.IBJU.2013.02.06 Comparison of radiographic and pathologic sizes of renal tumors Wei Chen, Linhui Wang, Qing Yang, Bing

More information

Patient Reported Weight Loss Predicts Recurrence Rate in Renal Cell Cancer Cases after Nephrectomy

Patient Reported Weight Loss Predicts Recurrence Rate in Renal Cell Cancer Cases after Nephrectomy DOI:10.22034/APJCP.2018.19.4.891 RESEARCH ARTICLE Editorial Process: Submission:01/04/2017 Acceptance:09/11/2017 Patient Reported Weight Loss Predicts Recurrence Rate in Renal Cell Cancer Cases after Nephrectomy

More information

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE WHAT IS THE ROLE OF ACTIVE SURVEILLANCE IN THE CONTEXT OF RENAL ABLATION AND PARTIAL NEPHRECTOMY? Alessandro Volpe University of Eastern Piedmont Novara, Italy RCC INCIDENCE SEER DATABASE (1975-2006) RCC

More information

Advanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6

Advanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6 Advanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6 Learning Objectives for this File: 1. Understand how clinical presentation drives the diagnostic workup 2. Recognize how patient education is

More information